# A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)

> **NCT07300267** · PHASE1 · RECRUITING · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 210 (estimated)

## Conditions studied

- Pneumococcal Infection

## Interventions

- **BIOLOGICAL:** V118C (Stage 1)
- **BIOLOGICAL:** V118C (Stage 2)
- **BIOLOGICAL:** PCV20 (Stage 1)
- **BIOLOGICAL:** PCV20 (Stage 2)

## Key facts

- **NCT ID:** NCT07300267
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-13
- **Primary completion:** 2028-10-24
- **Final completion:** 2029-05-25
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07300267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07300267, "A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07300267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*